Page last updated: 2024-08-24

aripiprazole and am 251

aripiprazole has been researched along with am 251 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashraf, NS; Cook, D; Costa, MDC; Dharia, RM; Dulchavsky, M; Fischer, S; Gestwicki, JE; Ivanova, MI; Joshi, G; Larsen, MJ; McQuade, TJ; Ouyang, M; Paulson, HL; Schapka, E; Sun, D; Todi, SV; Yang, Y	1

Other Studies

1 other study(ies) available for aripiprazole and am 251

Article	Year
Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3. Brain : a journal of neurology, 2016, 11-01, Volume: 139, Issue:11 Topics: Animals; Animals, Genetically Modified; Antipsychotic Agents; Aripiprazole; Ataxin-3; Brain; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Gene Expression Regulation; HEK293 Cells; Humans; Machado-Joseph Disease; Mice; Mutant Proteins; Nerve Tissue Proteins; Organ Culture Techniques; Peptides; Piperidines; Pyrans; Pyrazoles	2016

Article

Year

Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.

Brain : a journal of neurology, 2016, 11-01, Volume: 139, Issue:11

Topics: Animals; Animals, Genetically Modified; Antipsychotic Agents; Aripiprazole; Ataxin-3; Brain; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Gene Expression Regulation; HEK293 Cells; Humans; Machado-Joseph Disease; Mice; Mutant Proteins; Nerve Tissue Proteins; Organ Culture Techniques; Peptides; Piperidines; Pyrans; Pyrazoles

2016